ROCKWOOL A/S
ROCKWOOL A/S – transactions in connection with share buy-back programme
ROCKWOOL A/S – transactions in connection with share buy-back programme
Company announcement
for ROCKWOOL A/S
Release no. 05 – 2025
to Nasdaq Copenhagen
22 January 2025
ROCKWOOL A/S – transactions in connection with share buy-back programme
As mentioned in announcement no. 02/2024, ROCKWOOL A/S has initiated a share buy-back programme which will run from 8 February 2024 until 7 February 2025. During this period, the Company will buy own shares for up to a maximum of 160 MEUR.
The programme is implemented in accordance with EU Commission Regulation No 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation.
The following transactions have been executed during the period 15 – 21 January 2025:
Date | Number of B shares | Average purchase price B shares (DKK) | Aggregate amount, B shares (DKK) |
[Accumulated, last announcement] | 448,200 | 1,162,842,642 | |
15 January 2025 | 2,500 | 2,481.23 | 6,203,075 |
16 January 2025 | 2,500 | 2,485.29 | 6,213,225 |
17 January 2025 | 2,500 | 2,537.92 | 6,344,800 |
20 January 2025 | 2,000 | 2,565.13 | 5,130,260 |
21 January 2025 | 2,430 | 2,571.69 | 6,249,207 |
Accumulated under the programme (B shares) | 460,130 | 1,192,983,209 |
With the transactions stated above, ROCKWOOL A/S owns 514,013 B shares corresponding to 2.38 percent of the Company’s total share capital.
An overview showing the transaction data for the period 15 – 21 January 2025 is enclosed.
This concludes the share buy-back programme.
Further information:
Kim Junge Andersen
Senior Vice President, CFO
ROCKWOOL A/S
+45 46 55 80 15
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd16.9.2025 22:30:00 CEST | Press release
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
Society of Actuaries16.9.2025 20:46:16 CEST | Press release
Society of Actuaries Announces Planned CEO Succession in 2026
Lehman Brothers UK Capital Funding LP16.9.2025 17:53:36 CEST | Press release
Lehman Brothers UK Capital Funding LP: Notice of Proposed Interim Payment
Sampo plc16.9.2025 17:10:00 CEST | Press release
Sampo prices the issuance of new Restricted Tier 1 notes
Ringkjøbing Landbobank A/S16.9.2025 17:00:58 CEST | Pressemeddelelse
Ringkjøbing Landbobank udsteder Tier 2-kapital
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom